Levrix

Quick links to important sections

Levrix

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Levrix

Quick Facts

Property Description
Active ingredient Levocetirizine dihydrochloride
Form Film-coated tablets, Oral solution
Pharmacological class Second-generation antihistamine
Common use Relief of allergic conditions and hives
Origin Synthetic (Active metabolite)

What Type of Medicine is Levrix?

Levrix is a brand of synthetic medicinal product containing the active ingredient Levocetirizine dihydrochloride, which is officially classified as a highly selective second-generation antihistamine. The medication functions primarily as a Histamine H₁-receptor antagonist, designed for systemic use against various allergic conditions. The medication's high affinity for the H₁ receptor underscores its role in managing histamine-mediated symptoms. Unlike older classes, the second-generation antihistamine designation ensures that Levrix is clinically recognized for providing relief with a low potential for causing central nervous system effects, a key differentiating factor in patient care.

Composition and Purpose of Levocetirizine

The chemical core of Levrix is the pure, pharmacologically active component of Cetirizine, known as the R-enantiomer or active metabolite. This identity makes Levrix a focused, single-ingredient product. The general purpose of this synthetic compound is to mitigate the physiological discomfort and physical symptoms associated with various allergic conditions and hypersensitivity reactions. By selectively interfering with the effects of histamine, Levrix is used to relieve symptoms like a runny nose, sneezing, and the itching associated with uncomplicated hives.

Available Preparations and Systemic Use

The brand Levrix is typically marketed as film-coated tablets and is often available as an oral solution. Both preparations are designed for the oral route of administration, ensuring systemic use where the active ingredient is absorbed into the bloodstream to target allergic responses throughout the body. The availability of both solid and liquid forms ensures reliable and flexible administration of the Levocetirizine dihydrochloride active ingredient across different age groups and patient needs, an important consideration for a widely recognized allergy treatment.

What side effects are possible with Levrix?

Possible Side Effects and Safety Information

The safety profile for Levrix (levocetirizine) is categorized by the frequency of adverse reactions documented in clinical trials and post-marketing reports, as required by regulatory authorities.

Adverse Reactions by Frequency

Classification Examples of Documented Reactions
Common (1% to 10%) Somnolence (sleepiness), fatigue, dry mouth, pharyngitis (sore throat), nasopharyngitis (inflammation of the nose and throat), headache.
Uncommon (0.1% to 1%) Asthenia (unusual weakness or lack of energy), diarrhea, abdominal pain, pruritus (itching), rash.
Rare (0.01% to 0.1%) Tachycardia (fast heart rate), abnormal liver function tests, convulsions, oedema, aggression, weight gain.
Very Rare (<0.01%) Thrombocytopenia (low platelet count), hepatitis, anaphylactic shock (a severe allergic reaction), fixed drug eruption.

Serious and Clinically Significant Reactions

Serious adverse reactions reported in official documents include cases of Anaphylaxis (a potentially life-threatening allergic reaction), Angioedema (swelling beneath the skin), and Hepatitis.

The medicine has also been associated with Urinary Retention (the inability to empty the bladder completely). Caution is advised for patients with predisposing factors for urinary retention, such as a spinal cord lesion or prostatic hyperplasia.

Exposure-Related and Population-Specific Safety

Discontinuation-Related Risk

Regulatory agencies have noted a rare risk of severe pruritus (intense, widespread itching) developing after stopping the medicine following long-term, daily use (typically for several months or years). This reaction typically occurs within a few days of cessation.

Special Safety Considerations

Levrix is primarily eliminated by the kidneys. Official regulatory documents indicate that the medicine is contraindicated in patients with end-stage renal disease and those undergoing hemodialysis. A reduced dose is generally required for patients with moderate to severe renal (kidney) impairment and those with hepatic (liver) impairment to prevent potential drug accumulation and increased risk of side effects.


These safety classifications structure the official risk profile by defining both predictable common side effects and rare, severe events that necessitate clinical awareness. The inclusion of specific population-based cautions for renal and hepatic impairment defines mandatory adjustments based on the drug's metabolic and excretion pathways.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents detail specific manifestations of overdose for Levocetirizine dihydrochloride (Levrix) and outline mandated emergency procedures.

The clinical presentation of overdose differs significantly by age. In adults, the most commonly documented sign of overdose is drowsiness or excessive sedation. For children, however, the initial symptoms may involve agitation and restlessness, which subsequently progress into a state of drowsiness.

Due to the risk of severe outcomes, individuals must seek emergency medical attention immediately and contact a Poison Help line or emergency service if an overdose is suspected or confirmed.

Overdose Management Guidance Regulatory Statement
Antidote Status There is no known specific antidote to Levocetirizine dihydrochloride.
Treatment Approach Symptomatic or supportive treatment is the official recommended approach.
Drug Removal The drug is not effectively removed by dialysis; therefore, dialysis is stated to be ineffective for treatment.

Management of a suspected overdose focuses on providing supportive care. Procedures such as gastric lavage may be considered by medical professionals following a recent, short-term ingestion. All regulatory guidance emphasizes the need for immediate action and careful monitoring of the Central Nervous System effects, particularly given the difference in symptom clusters between adult and pediatric populations.

Therapeutic Uses of Levrix

Levrix is generally used to provide symptomatic relief across domains where additional symptomatic support is needed, offering supportive therapeutic benefit when symptoms related to heightened physiological activity become difficult to tolerate. It is considered relevant in clinical settings marked by episodic or fluctuating manifestations that require short-term symptomatic assistance. The medicine is applied in addressing two primary areas.


Relief from Allergic Rhinitis and Chronic Urticaria

The medication is commonly used to help with conditions characterized by periods of heightened symptoms, including seasonal allergic rhinitis (hay fever), perennial allergic rhinitis, and chronic idiopathic urticaria (CIU).

“Levrix plays a role in managing acute symptoms that often cluster together, providing support during difficult episodes.”

It is applied in addressing pronounced manifestations of allergic discomfort: rhinitis symptoms, such as frequent sneezing, bothersome rhinorrhea (runny nose), nasal pruritus (itching), and associated ocular symptoms; and cutaneous symptoms, primarily the intense pruritus (skin itching) and the physical presence of wheals (hives).

By moderating these manifestations, the medication may help with managing the overall symptom burden, which contributes to improved comfort during periods of heightened exposure and supports general well-being.


Quick Fact: Symptomatic Support for Persistent Pruritus

Levrix is relevant for easing challenging symptoms associated with chronic conditions like CIU, offering symptomatic support when persistent itching and hives interfere with routine activities.

Eligibility and Restrictions for Use

Levrix (levocetirizine dihydrochloride) is approved for use in specific populations as defined by regulatory health authorities. Eligibility is determined primarily by age, kidney function, and history of allergy to related medicines.

Contraindicated Populations

The medicine is formally contraindicated and must not be used by patients with a known hypersensitivity to the drug, its ingredients, or any piperazine derivatives, including cetirizine and hydroxyzine. Absolute non-eligibility also applies to patients with End-Stage Renal Disease (creatinine clearance less than 10 mL/min) and those undergoing hemodialysis. Additionally, regulatory labeling states that pediatric patients aged 6 months to 11 years with any degree of impaired kidney function must not use the medicine.

Age and Conditional Use

Age Group Eligibility Status
Adults and Adolescents (ge 12 years) Approved for use under standard conditions.
Children (ge 6 months) Approved via appropriate formulations (e.g., oral solution).
Infants (< 6 months) Safety and efficacy are not established by regulators.

For adults and adolescents, mild to severe renal impairment requires a conditional approach, necessitating an official adjustment to administration frequency. Use is also restricted, requiring caution, in patients with predisposing factors for urinary retention (such as prostatic hyperplasia) or a history of epilepsy.

What should I know about interactions with other medicines?

Levrix, which contains the active ingredient levocetirizine, can interact with other substances, primarily those that affect the central nervous system (CNS). These interactions can lead to increased side effects such as drowsiness, dizziness, poor concentration, or difficulty sleeping.

Important Interactions

It is essential to consult a healthcare professional before combining Levrix with any of the following:

  • Alcohol: Consuming alcohol while taking Levrix is generally not recommended as it can significantly worsen CNS depressant effects.
  • Central Nervous System (CNS) Depressants: This includes medications that cause sleepiness or reduced alertness. Examples are:
    • Sedatives, tranquilizers, or sleeping medicines (e.g., zolpidem, benzodiazepines like alprazolam).
    • Opioid pain relievers (e.g., oxycodone, hydrocodone).
    • Certain antidepressants or antipsychotics.
    • Other Antihistamines (especially first-generation ones like diphenhydramine) or cold and allergy medicines containing them, as this can increase the risk of side effects.

Other Considerations

  • Theophylline: Taking Levrix with theophylline (a medication for respiratory conditions) has been reported to cause a small decrease in levocetirizine clearance from the body, which may increase the risk of Levrix side effects.
  • Ritonavir: This antiviral medication may also affect how levocetirizine is processed by the body.

Always inform your doctor or pharmacist about all prescription and over-the-counter medicines, vitamins, and herbal supplements you are taking before starting treatment with Levrix.

Mechanism of Action

Levrix (levocetirizine) works by acting as a selective competitive antagonist and inverse agonist at the Histamine H1 receptors found throughout the periphery. This mechanism involves binding to the H1 receptor and stabilizing its inactive state, functionally preventing the inflammatory mediator histamine from attaching and initiating its signal. This molecular blockade suppresses the G q-protein signal transduction cascade that would otherwise follow histamine binding.

The resulting cellular inhibition modifies downstream signaling crucial for microcirculation and smooth muscle function. Specifically, this action limits histamine-induced increases in vascular permeability (fluid leakage from blood vessels) and inhibits the contraction of certain smooth muscles. The physiological consequence is the limitation of histamine-mediated extravasation of fluid into tissues and the inhibition of H1-mediated tissue changes. Levocetirizine's physiochemical properties ensure its action remains primarily peripheral, with minimal penetration of the blood-brain barrier at therapeutic levels.

Dosage and Administration Information

Levrix (levocetirizine dihydrochloride) is an oral medication administered systemically using either the film-coated tablet or the oral solution formulations. Proper use, including dosing and frequency, is governed by official guidelines, and the maximum recommended dose of 5 mg per day for adults should not be exceeded.


Standard Administration and Dosing

The daily dose is intended to be taken in a single intake, preferably in the evening. The medicine may be taken with or without food. The film-coated tablets are scored and may be broken to facilitate a lower dose where appropriate, while the oral solution requires a calibrated measuring device for accurate administration.

Age Group Recommended Daily Dose
Adults and Adolescents (ge 12 years) 5 mg once daily
Children 6 to 11 years 2.5 mg once daily
Children 6 months to 5 years 1.25 mg once daily (Oral Solution)

Use Patterns and Adjustments

The duration of use is typically guided by the pattern of symptoms: intermittent allergic rhinitis (symptoms less than four days per week or four weeks per year) allows treatment to be stopped and restarted as symptoms recur, while persistent allergic rhinitis may require continuous therapy.

Renal Impairment: Because levocetirizine is substantially excreted by the kidneys, dose adjustments are required for patients aged 12 and older with decreased renal function. For example, mild impairment (CLCR = 50-80 mL/min) suggests a dose of 2.5 mg once daily, while more severe impairment mandates reduced frequency. No dose adjustment is needed in patients with solely hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Levrix


Evidence for Use in Seasonal Allergic Rhinitis

Research exploring the active ingredient's role in seasonal allergic rhinitis (SAR) symptoms has primarily involved short-term, randomized controlled trials (RCTs). These studies were used in research exploring how symptoms change over time across various populations, including adults, adolescents, and children over 6 years old, who were experiencing periods of heightened symptom activity. The core research monitored outcomes related to physical discomfort and irritation, particularly by monitoring values of component-based symptom scores, such as sneezing, rhinorrhea (runny nose), and ocular (eye) symptoms.

Studies conducted during periods of increased symptom activity reported how symptoms evolved in the observed populations. The evidence base, largely derived from short-term trials lasting between one and six weeks, describes patterns measured during that specific study period.


Evidence for Use in Chronic Urticaria (Hives)

Research explored the active ingredient in studies evaluating Chronic Urticaria (CIU), a condition involving periods of heightened symptoms marked by both intense itching and the presence of wheals. Research was conducted using short-term, placebo-controlled randomized controlled trials. The main outcomes monitored were the severity and duration of pruritus and the size and number of wheals.

Clinical trials collected data on these cutaneous symptom endpoints over follow-up periods that were generally 4 to 6 weeks in duration. The findings describe the specific conditions under which these studies were conducted and contribute to the body of observed data in the study populations.


Evidence in Specific Patient Groups and Research Gaps

While research generally includes older children (over 6 years), studies exploring the active ingredient in younger children (ages 6 months to < 6 years) have focused primarily on understanding how the body processes the medication (pharmacokinetics) and on safety outcomes. Dedicated, well-designed efficacy trials using patient-reported outcomes describing perceived discomfort in this very young population are generally lacking.

Follow-up durations were limited in the core trials. Consequently, long-term effects are not fully established concerning the durability of response for sustained management of chronic conditions, and limited information for long-term outcomes remains a gap.

Frequently Asked Questions (FAQ)

Common questions about Levrix (FAQ)

Q: How quickly does Levrix usually start working?

Studies cited in official documents indicate that levocetirizine 5 mg was found to have an onset of action approximately 1 hour after being taken orally. The time it takes to notice effects may vary between individuals.

Q: How long does the effect of Levrix last?

The active ingredient levocetirizine is generally recommended to be taken as a single dose once daily. The long duration of action of the active ingredient, levocetirizine, supports its use for the relief of symptoms over a 24-hour period.

Q: What kind of side effects are most often reported with Levrix?

The most frequently reported adverse reactions are classified as common, occurring in 1% to 10% of patients during clinical trials. According to regulatory documents, these common side effects include somnolence (sleepiness), fatigue, and dry mouth.

Q: Can Levrix cause drowsiness or affect driving?

Side effects such as somnolence (sleepiness) and fatigue have been reported in official safety profiles. Patients are cautioned to consider their individual response to the medicine before driving a motor vehicle or operating machinery.

Q: Is it okay to take Levrix every day for long periods?

Official guidelines acknowledge that the medicine may be used for continuous therapy when managing conditions such as persistent allergic rhinitis. However, regulatory agencies have noted a rare risk of severe itching developing upon stopping the medicine following long-term, daily use.

Q: Can children safely use Levrix?

Official regulatory documents confirm that the medicine is approved for use in children starting at 6 months of age. Official use requires administration of the age-appropriate formulation (e.g., oral solution) according to the specific dosage guidelines set out in the product information.

Q: Can I take Levrix if I have a heart condition?

Official safety profiles list tachycardia (fast heart rate) and irregular heartbeat as rare adverse reactions documented in clinical trials and post-marketing reports. The risk of these effects is part of the drug's established safety profile.

Q: Can I take Levrix if I have kidney problems?

The medicine is contraindicated (must not be used) in patients with end-stage renal disease. For adults with milder kidney impairment, regulatory documents state that a dose adjustment is required.

Q: Can I take Levrix if I have liver issues?

Regulatory documents state that no dose adjustment is typically required in patients with solely hepatic (liver) impairment. However, rare adverse reactions such as hepatitis and abnormal liver function tests have been documented.

Q: Does Levrix affect blood pressure?

Official adverse reaction reports have documented the rare occurrence of both low blood pressure (hypotension) and high blood pressure (hypertension) as potential side effects of the medicine.

Q: Does Levrix work for all types of allergies?

The medicine is approved for use in relieving symptoms associated with seasonal and perennial (year-round) allergic rhinitis. It is also approved for the skin manifestations of uncomplicated chronic urticaria (hives).

Q: Does Levrix help with eye redness or watery eyes?

Official regulatory documents state that the medicine is approved for the temporary relief of symptoms associated with hay fever and other respiratory allergies, including itchy, watery eyes.

Q: Is Levrix known by a different name in other countries?

The active ingredient in Levrix is levocetirizine dihydrochloride. This same active ingredient is marketed globally under its generic name and other various brand names, such as Xyzal.

Q: How is Levrix related to the medicine called Xyzal or Zyrtec?

Official documents describe the active ingredient, levocetirizine, as the pharmacologically active component (R-enantiomer) of cetirizine. Cetirizine is the active ingredient found in the medicine known by the brand name Zyrtec.

Q: Is there a generic version of Levrix available?

The active ingredient in Levrix is levocetirizine dihydrochloride. This substance is available under its official generic name and other brand names, as detailed in official drug listings.

Q: Why do some people say Levrix is better than other over-the-counter options?

Official classification documents describe Levrix as a second-generation antihistamine. This category is clinically recognized for providing relief while demonstrating a low potential for central nervous system effects compared to older antihistamines.

Q: Does taking Levrix make you feel tired the next morning?

Somnolence (sleepiness) and fatigue are classified as common side effects of levocetirizine. Regulatory documents recommend taking the medicine once daily in the evening. This timing aligns with the intended management of potential somnolence effects during the day.

Q: Is it true that Levrix doesn't cause as much sedation as older medicines?

Levrix is classified as a second-generation antihistamine, a designation that means it is clinically recognized for providing relief with a low potential for causing central nervous system effects, compared to older classes of antihistamines.

Q: Are there any severe side effects associated with Levrix that require immediate attention?

Official regulatory documents describe rare but serious adverse reactions including anaphylaxis (a severe allergic reaction) and angioedema (swelling beneath the skin). Official documents define these reactions as potentially requiring urgent medical attention.

Q: Is Levrix known to cause weight gain?

Regulatory documents list weight gain as a rare adverse reaction (occurring in 0.01% to 0.1% of patients) documented during clinical trials and post-marketing reports.

Q: Are there studies supporting the use of Levrix for chronic conditions?

Research evidence has explored the active ingredient's role in the management of Chronic Urticaria (hives), which is defined as a long-lasting condition.

Q: Is Levrix used for skin issues, or mainly for nasal symptoms?

The medicine is used to relieve symptoms associated with both allergic conditions (such as a runny nose and sneezing) and the itching related to uncomplicated hives (a type of skin issue).

Q: Can taking Levrix affect lab test results?

Regulatory documents list abnormal liver function tests as a rare adverse reaction (occurring in 0.01% to 0.1% of patients) documented in clinical trials.

Q: Why is Levrix sometimes mentioned in discussions about insomnia?

Official drug information documents list difficulty sleeping as a potential side effect. The risk may increase, particularly if the medicine is taken with alcohol or other Central Nervous System (CNS) depressants.

Q: What age group is Levrix generally recommended for?

Official documents state that the medicine is approved for use in Adults and Adolescents (ge 12 years) and in Children starting at 6 months of age, with age-appropriate formulations and doses.

Q: Is Levrix effective for managing pet dander allergies?

The medicine is approved for use in relieving symptoms associated with perennial allergic rhinitis (year-round allergies). This category of allergy typically includes common indoor triggers like pet dander.

Q: Are there any known issues with taking Levrix and supplements?

Official drug interaction information provides a general caution to inform a healthcare professional about all prescription and over-the-counter medicines, vitamins, and herbal supplements before starting treatment.

Q: Is Levrix considered a non-drowsy medicine?

While Levrix is classified as a second-generation antihistamine, which generally has less sedation potential than older drugs, somnolence (sleepiness) is still listed in official documents as a common side effect, occurring in 1% to 10% of patients in clinical trials.

Q: Are there any documented cases of overdose with Levrix?

Official regulatory documents contain specific warnings and instructions in the event of an overdose. Regulatory documents include information regarding seeking medical assistance or contacting a Poison Control Center in the event that an overdose is suspected.

Q: How is Levrix described in official patient information leaflets?

Official patient information leaflets describe the medicine in accessible terms, focusing on its approved uses for allergic symptoms and hives, its warnings (e.g., drowsiness, kidney disease contraindications), and general directions for use.

Q: Why is it important to check the ingredients of other medicines when taking Levrix?

It is important to check other medicines for ingredients such as alcohol and other antihistamines or CNS depressants. Taking them concurrently with Levrix can significantly increase the risk of side effects such as drowsiness and dizziness.

Q: Does Levrix have an effect on mental clarity or focus?

Official warnings caution patients against engaging in hazardous occupations requiring complete mental alertness. This is due to the potential for side effects like drowsiness and dizziness, which may impair central nervous system performance.

Q: Does Levrix help with itching that is not caused by allergies?

The medicine is officially approved for the relief of symptoms, including itching, associated with uncomplicated chronic idiopathic urticaria (hives). This indication covers itching related to that specific condition.

Q: Are there specific warnings for older adults taking Levrix?

Official regulatory documents advise using the medicine with caution in older adults. The regulatory label recommends that individuals 65 years of age and older should consult a healthcare professional regarding appropriate dosing and use.

Q: Can I use Levrix while breastfeeding?

Official warnings state that the medicine is not recommended for use while breastfeeding. This caution is given because the active ingredient is expected to be excreted in breast milk.

How should Levrix be stored and disposed of?

Storage and Disposal Requirements

Scope Item Official Regulatory Requirement
Storage Temperature Store at Controlled Room Temperature (20 C to 25 C), with excursions permitted between 15 C and 30 C.
Protection Requirements Must be kept from freezing and protected from excess heat, moisture, and light.
Packaging Rules Must be stored in a closed container and kept in its original package.
Child Safety Must be stored out of the sight and reach of children to prevent accidental exposure.
Disposal Guidelines Do not use the medicine after the expiration date on the carton.
Unused medicine must not be disposed of via wastewater (flushing).
Dispose of expired or unused product through a drug take-back program or by following household disposal procedures for non-flush list medicines.

Official regulatory documents define how the product must be stored by requiring a specific temperature range, with a strict ban on freezing. The medication must be protected from environmental factors like heat and moisture, which may compromise stability. Disposal instructions mandate that the product should not be flushed and recommend using established pharmaceutical return methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Levrix found in:

A-Z Index: